-
By Canaccord Genuity Morning Coffee |
June 22, 2012
Shares of Onyx Pharmaceuticals soared after winning support from a U.S. advisory panel for its drug to treat a deadly blood cancer
-
By Press Release |
May 28, 2012
The Biotechnology Industry has shown investors some impressive gains this year. The SPDR S&P Biotech ETF (XBI) is up nearly 25% year-to-date.
-
By Canaccord Genuity Morning Coffee |
January 31, 2012
Shares of Amylin received a shot in the arm after its Bydureon diabetes drug won approval from U.S. regulators late Friday
-
By John L. Caiazzo |
January 29, 2012
Weekly analysis of all futures markets, including stock index futures and interest rates.
-
By John L. Caiazzo |
January 23, 2012
Weekly analysis of all futures markets, including stock index futures and interest rates.
-
By Canaccord Genuity Morning Coffee |
December 1, 2011
With Pfizer's patent on Lipitor expiring on Nov. 30, the company is preparing to defend its market share against at least two generic forms set to hit the markets
-
By Toni Hansen |
October 12, 2010
Short-term techncial and fundamental analysis of the E-mini stock index futures markets from Toni Hansen.